Prolactin and Prolactin Receptors Are Expressed and Functioning in Human Prostate

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1997 Feb 15

PMID 9045863

Citations 56

Authors

M T Nevalainen

E M Valve

P M Ingleton

M Nurmi

P M Martikainen

P L Harkonen

Affiliations

Soon will be listed here.

Abstract

Prolactin is widely expressed in different tissues, and it is presumed to have both local and systemic actions. In males it is known to influence reproductive functions but the significance and mechanisms of prolactin action in male accessory reproductive tissues are poorly understood. Here we show that prolactin acts as a direct growth and differentiation factor for human prostate, as measured by changes in DNA synthesis and epithelial morphology of organ cultures. Furthermore, we report the expression in human prostate of a short prolactin receptor form in addition to the long form, based upon ligand cross-linking studies and RT-PCR analysis of mRNA expression. The highest density of prolactin receptors was detected in the secretory epithelial cells by immunohistochemistry. Finally, we report that prolactin is locally produced in human prostate epithelium, as evidenced by marked prolactin immunoreactivity in a significant portion of prostate epithelial cells, with parallel expression of prolactin mRNA in human prostate. Collectively, these data provide significant support for the existence of an autocrine/paracrine loop of prolactin in the human prostate and may shed new light on the involvement of prolactin in the etiology and progression of neoplastic growth of the prostate.

Citing Articles

From pituitary cells to prostate gland in health and disease: direct and indirect endocrine connections.

Sarmento-Cabral A, Fuentes-Fayos A, Ordonez F, Leon-Gonzalez A, Martinez-Fuentes A, Gahete M Rev Endocr Metab Disord. 2025; .

PMID: 39910005 DOI: 10.1007/s11154-025-09948-7.

Stat5 induces androgen receptor () gene transcription in prostate cancer and offers a druggable pathway to target AR signaling.

Maranto C, Sabharwal L, Udhane V, Pitzen S, McCluskey B, Qi S Sci Adv. 2024; 10(9):eadi2742.

PMID: 38416822 PMC: 10901378. DOI: 10.1126/sciadv.adi2742.

PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling.

Yang T, Chi Y, Wang X, Xu C, Chen X, Liu Y Cell Death Dis. 2024; 15(2):128.

PMID: 38341429 PMC: 10858970. DOI: 10.1038/s41419-023-06362-2.

Rate of castration-induced prostate stroma regression is reduced in a mouse model of benign prostatic hyperplasia.

Zhang R, Singh S, Pan C, Xu B, Kindblom J, Eng K Am J Clin Exp Urol. 2023; 11(1):12-26.

PMID: 36923722 PMC: 10009314.

The Involvement of Prolactin in Stress-Related Disorders.

Faron-Gorecka A, Latocha K, Pabian P, Kolasa M, Sobczyk-Krupiarz I, Dziedzicka-Wasylewska M Int J Environ Res Public Health. 2023; 20(4).

PMID: 36833950 PMC: 9959798. DOI: 10.3390/ijerph20043257.

References

McKeehan W, Adams P, Fast D . Different hormonal requirements for androgen-independent growth of normal and tumor epithelial cells from rat prostate. In Vitro Cell Dev Biol. 1987; 23(2):147-52. DOI: 10.1007/BF02623596. View

Prins G . Prolactin influence on cytosol and nuclear androgen receptors in the ventral, dorsal, and lateral lobes of the rat prostate. Endocrinology. 1987; 120(4):1457-64. DOI: 10.1210/endo-120-4-1457. View

Rui H, Purvis K . Prolactin selectively stimulates ornithine decarboxylase in the lateral lobe of the rat prostate. Mol Cell Endocrinol. 1987; 50(1-2):89-97. DOI: 10.1016/0303-7207(87)90080-3. View

Bonkhoff H, Stein U, Remberger K . Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum Pathol. 1995; 26(2):167-70. DOI: 10.1016/0046-8177(95)90033-0. View

Clevenger C, Chang W, Ngo W, Pasha T, Montone K, Tomaszewski J . Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am J Pathol. 1995; 146(3):695-705. PMC: 1869171. View

Fuh G, Wells J . Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J Biol Chem. 1995; 270(22):13133-7. DOI: 10.1074/jbc.270.22.13133. View

Martikainen P, Harkonen P, Vanhala T, Makela S, Viljanen M, Suominen J . Multihormonal control of synthesis and secretion of prostatein in cultured rat ventral prostate. Endocrinology. 1987; 121(2):604-11. DOI: 10.1210/endo-121-2-604. View

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

Martikainen P . Maintenance of adult rat ventral prostate in organ culture. Anat Rec. 1987; 218(2):166-74. DOI: 10.1002/ar.1092180212. View

10.

Boutin J, Jolicoeur C, Okamura H, Gagnon J, Edery M, Shirota M . Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell. 1988; 53(1):69-77. DOI: 10.1016/0092-8674(88)90488-6. View

11.

Sissom J, Eigenbrodt M, Porter J . Anti-growth action on mouse mammary and prostate glands of a monoclonal antibody to prolactin receptor. Am J Pathol. 1988; 133(3):589-95. PMC: 1880813. View

12.

Chang S, Chung L . Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology. 1989; 125(5):2719-27. DOI: 10.1210/endo-125-5-2719. View

13.

Boutin J, Edery M, Shirota M, Jolicoeur C, Lesueur L, Ali S . Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol Endocrinol. 1989; 3(9):1455-61. DOI: 10.1210/mend-3-9-1455. View

14.

. Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells. Mol Cell Endocrinol. 1990; 68(1):21-8. DOI: 10.1016/0303-7207(90)90165-5. View

15.

Ginsburg E, Vonderhaar B . Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 1995; 55(12):2591-5. View

16.

MERSHON J, Sall W, Mitchner N, Ben-Jonathan N . Prolactin is a local growth factor in rat mammary tumors. Endocrinology. 1995; 136(8):3619-23. DOI: 10.1210/endo.136.8.7628401. View

17.

Sinha Y . Structural variants of prolactin: occurrence and physiological significance. Endocr Rev. 1995; 16(3):354-69. DOI: 10.1210/edrv-16-3-354. View

18.

Reiter E, Lardinois S, Klug M, Sente B, Hennuy B, Bruyninx M . Androgen-independent effects of prolactin on the different lobes of the immature rat prostate. Mol Cell Endocrinol. 1995; 112(1):113-22. DOI: 10.1016/0303-7207(95)03596-y. View

19.

Wu H, Devi R, Malarkey W . Expression and localization of prolactin messenger ribonucleic acid in the human immune system. Endocrinology. 1996; 137(1):349-53. DOI: 10.1210/endo.137.1.8536634. View

20.

Das R, Vonderhaar B . Transduction of prolactin's (PRL) growth signal through both long and short forms of the PRL receptor. Mol Endocrinol. 1995; 9(12):1750-9. DOI: 10.1210/mend.9.12.8614411. View